Darwish Basma, Stochino-Loi Emanuela, Pasquier Geoffroy, Dugardin Fabrice, Defortescu Guillaume, Abo Carole, Roman Horace
Expert Center in Diagnostic and Management of Endometriosis, Department of Gynecology and Obstetrics, Rouen University Hospital, Rouen, France.
Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy.
J Minim Invasive Gynecol. 2017 Sep-Oct;24(6):998-1006. doi: 10.1016/j.jmig.2017.06.005. Epub 2017 Jun 15.
To report the outcomes of surgical management of urinary tract endometriosis.
Retrospective study based on prospectively recorded data (NCT02294825) (Canadian Task Force classification II-3).
University tertiary referral center.
Eighty-one women treated for urinary tract endometriosis between July 2009 and December 2015 were included, including 39 with bladder endometriosis, 31 with ureteral endometriosis, and 11 with both ureteral and bladder endometriosis. Owing to bilateral ureteral localization in 8 women, 50 different ureteral procedures were recorded.
Procedures performed included resection of bladder endometriosis nodules, advanced ureterolysis, ureteral resection followed by end-to-end anastomosis, and ureteroneocystostomy.
The main outcome measure was the outcome of the surgical management of urinary tract endometriosis. Fifty women presented with deep infiltrating endometriosis (DIE) of the bladder and underwent either full-thickness excision of the nodule (70%) or excision of the bladder wall without opening of the bladder (30%). Ureteral lesions were treated by ureterolysis in 78% of the patients and by primary segmental resection in 22%. No patient required nephrectomy. Histological analysis revealed intrinsic ureteral endometriosis in 54.5% of cases. Clavien-Dindo grade III complications were present in 16% of the patients who underwent surgery for ureteral nodules and in 8% of those who underwent surgery for bladder endometriosis. Overall delayed postoperative outcomes were favorable regarding urinary symptoms and fertility. Patients were followed up for a minimum of 12 months and a maximum of 7 years postoperatively, with no recorded recurrences.
Surgical outcomes of urinary tract endometriosis are generally satisfactory; however, the risk of postoperative complications should be taken into consideration. Therefore, all such procedures should be managed by an experienced multidisciplinary team.
报告泌尿道子宫内膜异位症的手术治疗结果。
基于前瞻性记录数据的回顾性研究(NCT02294825)(加拿大工作组分类II-3)。
大学三级转诊中心。
纳入2009年7月至2015年12月期间接受泌尿道子宫内膜异位症治疗的81名女性,其中39例为膀胱子宫内膜异位症,31例为输尿管子宫内膜异位症,11例同时患有输尿管和膀胱子宫内膜异位症。由于8名女性双侧输尿管受累,共记录了50例不同的输尿管手术。
所实施的手术包括膀胱子宫内膜异位结节切除术、高级输尿管松解术、输尿管切除后端端吻合术以及输尿管膀胱吻合术。
主要测量指标为泌尿道子宫内膜异位症的手术治疗结果。50名女性存在膀胱深部浸润性子宫内膜异位症(DIE),其中70%接受了结节全层切除术,30%接受了未打开膀胱的膀胱壁切除术。78%的患者输尿管病变采用输尿管松解术治疗,22%采用一期节段性切除术治疗。无患者需要进行肾切除术。组织学分析显示54.5%的病例存在输尿管原发性子宫内膜异位症。接受输尿管结节手术的患者中有16%出现Clavien-Dindo III级并发症,接受膀胱子宫内膜异位症手术的患者中有8%出现该并发症。总体而言,术后延迟结局在泌尿系统症状和生育能力方面良好。患者术后随访时间最短12个月,最长7年,无复发记录。
泌尿道子宫内膜异位症的手术结果总体令人满意;然而,应考虑术后并发症的风险。因此,所有此类手术应由经验丰富的多学科团队进行管理。